What is CRMD's P/E ratio?

Cormedix Inc (CRMD) currently trades at a P/E ratio of 3.27.

Cormedix Inc reports a Return on Equity (ROE) of 41.42%.

What is CRMD's dividend yield?

Cormedix Inc offers a dividend yield of 0.00%.

What is CRMD's Quality Score?

Our AI rates CRMD's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CRMD?

Our AI Timing Score for CRMD is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CRMD belong to?

Cormedix Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Cormedix Inc (CRMD) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

CRMD AI Analysis Summary

Our AI summary for CRMD: Cormedix Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 3.27, ROE of 41.42%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CRMD

Cormedix Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 97

USD 7.52

-0.03 (-0.40%) Day Change

Watchlist Portfolio Compare Chart

3.27

P/E

0.33

D/E

41.4%

ROE

22.2%

ROA

0.00%

Div Yield

-0.01

PEG

CORMEDIX INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 7.52 Price -0.03 (-0.40%) Day Change	NEWS SCORE: 97

CRMD, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

58%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	97
Magic Formula Rank by ROA	67 GOOD
Magic Formula Rank by ROE	67 GOOD
Magic Formula Rank by ROIC	136
Price	7.52
PBV / Sector	1.36 / 44,022.72 GOOD
Earning Per Share	2.30

PE / Sector	3.27 / 19.17 GREAT
PEG or PE/Growth / Sector	-0.01 / 1.24
Average 1M Daily Value	6.94 M
Average 1W Daily Value	6.84 M

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	45.25 / 98.24 GREAT
NPM Average (%) / Sector	-11,338.40 / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	22.19 / 185,260.96 GOOD
ROA Average (%) / Sector	-15.50 / 36,684.70
ROA Change Average (%) / Sector	-68.43 / 422,221.66
ROE (%) / Sector	41.42 / 243,762.23 GREAT
ROE Average (%) / Sector	-11.91 / 48,758.47
ROE Change Average (%) / Sector	-83.12 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:02
Symbol	CRMD
Name	CORMEDIX INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	78.45 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	592.31 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 389 Interpace Pkwy, Parsippany, NJ, United States, 07054

Phone: 908 517 9500

Website: https://cormedix.com

Employees: 191

Sector: Healthcare >> Biotechnology

Description: CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.